- Country: Argentina
- Summary: Pharmacy - Pamidronato, Potassium Solution, Sodium, Pramipexol, Etc - Farma 28, 32 and 35-2025
- ART Ref No: 123809321
- Deadline: 05 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: ARS 1579656.00
- Notice Type: Tender
- Document Ref. No.: 418-1207-CDI25
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Dysodic pamidronate. Model: 90 mg, injectable, lyophilized, in blister bottle, phosphate potassium solution. Model: with 3 mmol of phosphorus and 4.4 meq of potassium per milliliter, in ampoule x 10 ml, intravenous, sterile and apirogenic use, phosphate sodium solution. Model: with 3 mmol of phosphorus and 4 sodium meq by millilitro, in ampoule x 10 ml, intravenous, sterile and apirogenic use, pramipexol. Model: 1 mg, in tablet, amantadine. Model: 100 mg (as hydrochloride), in tablet
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPharmacy - Pamidronato, Potassium Solution, Sodium, Pramipexol, Etc - Farma 28, 32 and 35-2025 - Argentina Tender
The HTAL. JUAN A. FERNANDEZ, a Government sector organization in Argentina, has announced a new tender for Pharmacy - Pamidronato, Potassium Solution, Sodium, Pramipexol, Etc - Farma 28, 32 and 35-2025. This tender is published on ArgentinaTenders under ART Ref No: 123809321 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-05.
The estimated tender value is ARS 1579656.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
